Takeda Pharmaceutical Co Ltd (TAK)
13.62
+0.06
(+0.41%)
USD |
NYSE |
Nov 15, 16:00
13.62
0.00 (0.00%)
After-Hours: 16:24
Takeda Pharmaceutical Profit Margin (Quarterly): 7.83% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.83% |
| June 30, 2024 | 7.88% |
| March 31, 2024 | -0.29% |
| December 31, 2023 | 9.51% |
| September 30, 2023 | -4.60% |
| June 30, 2023 | 8.44% |
| March 31, 2023 | 3.26% |
| December 31, 2022 | 10.86% |
| September 30, 2022 | 6.16% |
| June 30, 2022 | 10.80% |
| March 31, 2022 | -1.30% |
| December 31, 2021 | 6.41% |
| September 30, 2021 | 5.44% |
| June 30, 2021 | 14.50% |
| March 31, 2021 | 25.59% |
| December 31, 2020 | 11.04% |
| September 30, 2020 | 0.51% |
| June 30, 2020 | 10.29% |
| March 31, 2020 | 0.22% |
| December 31, 2019 | -3.75% |
| September 30, 2019 | 8.35% |
| June 30, 2019 | 0.83% |
| March 31, 2019 | -4.08% |
| December 31, 2018 | 7.56% |
| September 30, 2018 | 11.24% |
| Date | Value |
|---|---|
| June 30, 2018 | 17.39% |
| March 31, 2018 | -13.47% |
| December 31, 2017 | 13.95% |
| September 30, 2017 | 6.47% |
| June 30, 2017 | 32.30% |
| March 31, 2017 | -12.19% |
| December 31, 2016 | 8.90% |
| September 30, 2016 | 5.94% |
| June 30, 2016 | 22.93% |
| March 31, 2016 | -8.08% |
| December 31, 2015 | 12.11% |
| September 30, 2015 | 6.51% |
| June 30, 2015 | 5.51% |
| March 31, 2015 | -51.51% |
| December 31, 2014 | 3.75% |
| September 30, 2014 | 6.37% |
| June 30, 2014 | 8.12% |
| March 31, 2014 | -6.58% |
| December 31, 2013 | 11.89% |
| September 30, 2013 | 10.25% |
| June 30, 2013 | 8.76% |
| March 31, 2013 | 2.63% |
| December 31, 2012 | 4.75% |
| September 30, 2012 | 8.29% |
| June 30, 2012 | 21.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.60%
Minimum
Sep 2023
25.59%
Maximum
Mar 2021
6.44%
Average
7.12%
Median
Profit Margin (Quarterly) Benchmarks
| HUTCHMED (China) Ltd | -- |
| Astellas Pharma Inc | 7.95% |
| Nxera Pharma Co Ltd | 12.95% |
| PeptiDream Inc | 58.82% |
| Healios KK | -107.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.01% |
| Return on Assets | 1.91% |
| Return on Invested Capital | 2.37% |
| Gross Profit Margin (Quarterly) | 66.47% |
| Operating Margin (Quarterly) | 23.27% |
| Return on Net Operating Assets | 2.13% |